Marshall Wace North America’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-185,147
| Closed | -$30M | – | 1562 |
|
|
2021
Q2 | $30M | Sell |
185,147
-41,456
| -18% | -$6.71M | 0.12% | 169 |
|
|
2021
Q1 | $18.2M | Sell |
226,603
-253,475
| -53% | -$20.3M | 0.08% | 266 |
|
|
2020
Q4 | $26.1M | Buy |
+480,078
| New | +$26.1M | 0.12% | 200 |
|
|
2020
Q2 | – | Sell |
-5,771
| Closed | -$71K | – | 1371 |
|
|
2020
Q1 | $71K | Buy |
+5,771
| New | +$71K | ﹤0.01% | 1041 |
|